ALFA Finder| Revenue growth | 29% YoY Q1FY27 |
|---|---|
| Margins | EBITDA margin 41%; Gross margin 89% |
| Demand visibility | 33% YoY IPD increase; 10M+ social media followers |
| Management confidence | Strong momentum in both services and products |
Growth
Revenue grew 29% YoY; PAT increased 28% YoY to Rs 65.7 Cr. Healthcare products saw 47% YoY growth.
Outlook
Adding 450 beds in pipeline; 12-18 month payback for 100-bed facilities; targeting new plant-based protein and joint care launches.
Risks
High dependence on founder's social media funnel; transition to Ind AS accounting standards.
Last quarter's promises, checked
Delivered
- Guided 2,800-3,000 beds in 3-4 months → Delivered 2,400 operational + 450 in pipeline (= BEAT)
- Guided 50-50 revenue mix → Delivered 53% products / 47% services (= BEAT)
- Guided 44-46% EBITDA margin → Delivered 41% Q1FY27 (= PARTIAL)
Partly delivered
- Guided 4x-5x PAT growth over 4 years → Q1FY27 PAT +28% YoY (= PARTIAL)
Investor Presentation filed with BSE, NSE: JSLL. Summary written with AI assistance from the document.
Jeena Sikho Lifecare Ltd: key numbers
- Share price
- ₹367.95
- Market cap
- ₹4,575 Cr
- Revenue (annual)
- ₹801.4 Cr
- Net profit (annual)
- ₹221.8 Cr
- P/E (TTM)
- 19.3×Sector 43.8×
- Promoter holding
- 63.67%+0.05% QoQ
- FII holding
- 4.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jeena Sikho Lifecare Ltd
All →Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
Jeena Sikho Lifecare Merger & Restructuring Worth ₹0.03 Cr
Jeena Sikho Lifecare's board approved incorporating Ayugenomics Private Limited as a subsidiary, holding 60%. The company will invest Rs 3 lakh, subject to statutory approvals.
- Value
- ₹0.03 Cr
Jeena Sikho Lifecare Board Meeting Date
Jeena Sikho Lifecare has scheduled a board meeting for 14 Nov 2026 to consider unaudited Q1 FY27 financial results. The trading window is closed from 1 Oct to 16 Nov 2026.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Jeena Sikho Lifecare Employee Stock Options
Jeena Sikho Lifecare allotted 23,374 equity shares under its ESOS 2024 scheme. This allotment increases the company's total paid-up equity share capital.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare Limited has launched eight new Ayurvedic healthcare, wellness, and nutraceutical products. These new offerings are now available in the domestic market.